Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Tumour immunogenicity, antigen presentation, and immunological barriers in cancer immunotherapy
doi: 10.1016/j.bbr.2015.02.044 113 NaseribafroueiAHestadKAvershinaESekeljaMLinlkkenAWilsonRet al
Because not all protocols are created equal
Following administration in animal models: BPC-157 demonstrates rapid systemic distribution within 15-30 minutes of administration TB-500 shows tissue-specific accumulation with preferential uptake in injured areas GHK-Cu exhibits copper-mediated transport and tissue binding characteristics Combined formulation provides both immediate and sustained bioactivity Distribution studies suggest that while each peptide follows distinct pathways, injury sites tend to concentrate all three components, potentially enhancing local therapeutic effects through multiple mechanisms
US$ 22.90
US$ 26.46
US$ 25.56
US$ 26.79
US$ 24.02
US$ 20.02
US$ 27.89
US$ 25.79
US$ 28.42
US$ 26.64
